PE-22-28 Peptide: A Breakthrough in Neurological Research
Exploring the potential of PE-22-28 peptide for mood, memory, and neuroprotection.
Get a Quote & SampleProduct Core Value
PE-22-28 Peptide
PE-22-28 is a synthetic peptide analog of spadin, acting as a potent TREK-1 inhibitor. It shows significant promise in research for its ability to promote neurogenesis, offering potential therapeutic benefits for depression, neurodegenerative diseases, and cognitive enhancement.
- Discover the potential antidepressant activity of PE-22-28 peptide for depression, offering novel pathways for treatment.
- Explore the critical role of PE-22-28 in neurogenesis research, understanding its impact on brain cell growth.
- Learn about the mechanism of action of PE-22-28, focusing on its TREK-1 inhibition capabilities.
- Investigate PE-22-28's potential applications in post-stroke depression and its impact on neurological health.
Key Advantages of PE-22-28
Enhanced Stability and Potency
PE-22-28, as a shortened analog of spadin, exhibits improved in vivo stability and greater TREK-1 channel inhibition, making it a highly effective tool for research.
Mood Regulation and Antidepressant Effects
Research into PE-22-28 peptide for depression suggests it can help regulate mood and potentially alleviate depressive symptoms through its unique biological pathways.
Cognitive Function Support
With its influence on neurogenesis and synaptic plasticity, PE-22-28 may offer nootropic benefits, supporting learning, memory, and overall cognitive function.
Key Applications
Depression Research
Utilizing PE-22-28's antidepressant activity to understand and combat depressive disorders.
Neurogenesis Studies
Investigating how PE-22-28 peptide promotes the growth of new neurons and neural connections.
Stroke Recovery
Exploring the potential of PE-22-28 in mitigating post-stroke depression and supporting brain repair.
Nootropic Research
Examining PE-22-28's capacity to enhance cognitive functions like memory and learning.